Birth order, interpregnancy interval and birth outcomes among Filipino infants

J E Miller1

  • 1Office of Population Research, Princeton University.

Insights

First births face the most risks. High birth order and short interpregnancy intervals combined increase risks, but this high-risk group is small, limiting overall impact on birth outcomes.

Area of Science:

  • Maternal and Child Health
  • Perinatal Epidemiology
  • Demography

Background:

  • Birth order and interpregnancy interval are known factors influencing infant health.
  • Previous research indicates potential risks associated with specific birth circumstances.

Purpose of the Study:

  • To investigate the combined effects of birth order and interpregnancy interval on various birth outcomes.
  • To identify specific high-risk groups for adverse birth outcomes.

Main Methods:

  • Analysis of data from a longitudinal study of 2063 births in the Philippines.
  • Statistical modeling to assess the impact of birth order and interpregnancy interval on birthweight, gestational age, and other infant metrics.
  • Control for confounding factors including maternal age, education, smoking, health history, and nutritional status.

Main Results:

  • First births were found to be the most disadvantaged across all birth order and spacing categories.
  • Combined risks of short interpregnancy intervals (< 6 months) and high birth order (≥ 5th) were significant.
  • These combined risks were specific to infants with both attributes; no excess risk was observed for lower-order births with short intervals or high-order births with long intervals.
  • The observed patterns held true for all five birth outcomes and neonatal mortality, even after controlling for covariates.

Conclusions:

  • The combination of high birth order and short interpregnancy interval poses the greatest risk to infant health outcomes.
  • Interventions targeting this specific high-risk group (fewer than 2% of births) may have a limited impact (1-2%) on reducing overall low birthweight and neonatal mortality.
  • Understanding these nuanced relationships is crucial for optimizing maternal and child health strategies.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...